Filing Details
- Accession Number:
- 0001209191-17-041267
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-21 20:19:25
- Reporting Period:
- 2017-06-16
- Filing Date:
- 2017-06-21
- Accepted Time:
- 2017-06-21 20:19:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
876343 | Biotime Inc | BTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1325697 | J Deborah Andrews | 1911 Walker Avenue Monrovia CA 91016 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Acquisiton | 2017-06-16 | 2,000 | $2.95 | 6,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Shares | Option to Purchase Common Shares | $2.72 | 2021-06-30 | 20,000 | 20,000 | Direct | |
Common Shares | Option to Purchase Common Shares | $3.57 | 2020-06-30 | 20,000 | 20,000 | Direct | |
Common Shares | Option to Purchase Common Shares | $3.11 | 2019-06-30 | 20,000 | 20,000 | Direct | |
Common Shares | Option to Purchase Common Shares | $2.86 | 2019-04-10 | 20,000 | 20,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-06-30 | 20,000 | 20,000 | Direct |
2020-06-30 | 20,000 | 20,000 | Direct |
2019-06-30 | 20,000 | 20,000 | Direct |
2019-04-10 | 20,000 | 20,000 | Direct |
Footnotes
- 5,000 options became exercisable on September 30, 2016; December 31, 2016; and March 31, 2017. The remaining 5,000 options will become exercisable on June 30, 2017 based upon continued service on the board of directors.
- Became exercisable in four equal quarterly installments after the date of grant on July 1, 2015.
- Became exercisable in four equal quarterly installments after the date of grant on July 1, 2014.
- Became exercisable in four equal quarterly installments after the date of grant on April 11, 2014.